The modulation of topoisomerase I-mediated DNA cleavage and the induction of DNA-topoisomerase I crosslinks by crotonaldehyde-derived DNA adducts

Nucleic Acids Research

Volumn 36, Issue 12, 2008, Pages 4128-4136

  Dexheimer, Thomas S ^a   Kozekova, Albena ^b   Rizzo, Carmelo J ^b   Stone, Michael P ^b   Pommier, Yves ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE; CROTONALDEHYDE; DEOXYGUANOSINE; DNA TOPOISOMERASE; DOUBLE STRANDED DNA; OLIGONUCLEOTIDE; SCHIFF BASE; SODIUM BOROHYDRIDE;

ANIMAL CELL; ARTICLE; CARCINOGEN DNA INTERACTION; CARCINOGENICITY; COMPLEX FORMATION; CONTROLLED STUDY; DNA ADDUCT; DNA CLEAVAGE; DNA CROSS LINKING; ENZYME ACTIVITY; MAMMAL CELL; MUTAGENICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN CROSS LINKING; RING OPENING;

ALDEHYDES; CELL LINE; DNA ADDUCTS; DNA TOPOISOMERASES, TYPE I; HUMANS; OLIGODEOXYRIBONUCLEOTIDES; STEREOISOMERISM;

MAMMALIA;

EID: 47249094200     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkn334     Document Type: Article

References (46)

1. International Agency for Research on Cancer. (1995) IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Dry Cleaning, Some Chlorinated Solvents and Other Industrial Chemical. International Agency for Research on Cancer, Lyon, France.
2. Chung,F.L., Chen,H.J. and Nath,R.G. (1996) Lipid peroxidation as a potential endogenous source for the formation of exocyclic DNA adducts. Carcinogenesis, 17, 2105-2111.
3. Wang,M.Y., Chung,F.L. and Hecht,S.S. (1988) Identification of crotonaldehyde as a hepatic microsomal metabolite formed by α-hydroxylation of the carcinogen N-nitrosopyrrolidine. Chem. Res. Toxicol., 1, 28-31.
4. Hecht,S.S., Upadhyaya,P. and Wang,M. (1999) Reactions of α-acetoxy-N-nitrosopyrrolidine and crotonaldehyde with DNA. IARC Sci. Publ., 125, 147-154.
5. Neudecker,T., Eder,E., Deininger,C. and Henschler,D. (1989) Crotonaldehyde is mutagenic in Salmonella typhimurium TA100. Environ. Mol. Mutagen., 14, 146-148.
6. Neudecker,T., Lutz,D., Eder,E. and Henschler,D. (1981) Crotonaldehyde is mutagenic in a modified Salmonella typhimurium mutagenicity testing system. Mutat. Res., 91, 27-31.
7. Czerny,C., Eder,E. and Runger,T.M. (1998) Genotoxicity and mutagenicity of the α, β-unsaturated carbonyl compound crotonaldehyde (butenal) on a plasmid shuttle vector. Mutat. Res., 407, 125-134.
8. Fernandes,P.H., Kanuri,M., Nechev,L.V., Harris,T.M. and Lloyd,R.S. (2005) Mammalian cell mutagenesis of the DNA adducts of vinyl chloride and crotonaldehyde. Environ. Mol. Mutagen., 45, 455-459.
9. Chung,F.L., Tanaka,T. and Hecht,S.S. (1986) Induction of liver tumors in F344 rats by crotonaldehyde. Cancer Res., 46, 1285-1289.
10. 2-adducts by reaction of deoxyguanosine with α-acetoxy-N-nitrosopyrrolidine, 4-(carbethoxynitrosamino)butanal, or crotonaldehyde. Cancer Res., 43, 1230-1235.
11. 2 propanodeoxyguanosine adducts in DNA upon reaction with acrolein or crotonaldehyde. Cancer Res., 44, 990-995.
12. Winter,C.K., Segall,H.J. and Haddon,W.F. (1986) Formation of cyclic adducts of deoxyguanosine with the aldehydes trans- 4-hydroxy-2-hexenal and trans-4-hydroxy-2-nonenal in vitro. Cancer Res., 46, 5682-5686.
13. 32P-post-labeling technique after per os application of crotonaldehyde. Carcinogenesis, 21, 1191-1196.
14. Chung,F.L., Nath,R.G., Nagao,M., Nishikawa,A., Zhou,G.D. and Randerath,K. (1999) Endogenous formation and significance of 1,N 2-propanodeoxyguanosine adducts. Mutat. Res., 424, 71-81.
15. Nath,R.G. and Chung,F.L. (1994) Detection of exocyclic 1,N 2-propanodeoxyguanosine adducts as common DNA lesions in rodents and humans. Proc. Natl Acad. Sci. USA, 91, 7491-7495.
16. Nath,R.G., Ocando,J.E. and Chung,F.L. (1996) Detection of 1,N 2-propanodeoxyguanosine adducts as potential endogenous DNA lesions in rodent and human tissues. Cancer Res., 56, 452-456.
17. Zhang,S., Villalta,P.W., Wang,M. and Hecht,S.S. (2006) Analysis of crotonaldehyde- and acetaldehyde-derived 1,N 2-propanodeoxyguanosine adducts in DNA from human tissues using liquid chromatography electrospray ionization tandem mass spectrometry. Chem. Res. Toxicol., 19, 1386-1392.
18. Lao,Y. and Hecht,S.S. (2005) Synthesis and properties of an acetaldehyde-derived oligonucleotide interstrand cross-link. Chem. Res. Toxicol., 18, 711-721.
19. Nechev,L.V., Kozekov,I., Harris,C.M. and Harris,T.M. (2001) Stereospecific synthesis of oligonucleotides containing crotonaldehyde adducts of deoxyguanosine. Chem. Res. Toxicol., 14, 1506-1512.
20. 3-γ-OH-1, N 2-propano-2′-deoxyguanosine adducts in the 5′-CpG-3′ sequence. Chem. Res. Toxicol., 19, 195-208.
21. Kozekov,I.D., Nechev,L.V., Moseley,M.S., Harris,C.M., Rizzo,C.J., Stone,M.P. and Harris,T.M. (2003) DNA interchain cross-links formed by acrolein and crotonaldehyde. J. Am. Chem. Soc., 125, 50-61.
22. Wang,M., McIntee,E.J., Cheng,G., Shi,Y., Villalta,P.W. and Hecht,S.S. (2000) Identification of DNA adducts of acetaldehyde. Chem. Res. Toxicol., 13, 1149-1157.
23. 2-deoxyguanosine adducts of acrolein, crotonaldehyde, and trans-4-hydroxynonenal cross-link to peptides via Schiff base linkage. J. Biol. Chem., 278, 5970-5976.
24. Kuykendall,J.R. and Bogdanffy,M.S. (1992) Efficiency of DNA-histone crosslinking induced by saturated and unsaturated aldehydes in vitro. Mutat. Res., 283, 131-136.
25. 2- propano-2′-deoxyguanosine in the 5′-CpG-3′ DNA sequence. Biochemistry, 46, 2608-2621.
26. 2 [3-Oxo-1(S)-methyl-propyl]-dG DNA adduct hinders interstrand cross-link formation in the 5′-CpG-3′ sequence. Chem. Res. Toxicol., 19, 1019-1029.
27. Shaw,J.L., Blanco,J. and Mueller,G.C. (1975) A simple procedure for isolation of DNA, RNA and protein fractions from cultured animal cells. Anal. Biochem., 65, 125-131.
28. Takagi,K., Dexheimer,T.S., Redon,C., Sordet,O., Agama,K., Lavielle,G., Pierre,A., Bates,S.E. and Pommier,Y. (2007) Novel E-ring camptothecin keto analogues (S38809 and S39625) are stable, potent, and selective topoisomerase I inhibitors without being substrates of drug efflux transporters. Mol. Cancer. Ther., 6, 3229-3238.
29. Bonven,B.J., Gocke,E. and Westergaard,O. (1985) A high affinity topoisomerase I binding sequence is clustered at DNAase I hypersensitive sites in Tetrahymena R-chromatin. Cell, 41, 541-551.
30. Pourquier,P., Ueng,L.M., Fertala,J., Wang,D., Park,H.J., Essigmann,J.M., Bjornsti,M.A. and Pommier,Y. (1999) Induction of reversible complexes between eukaryotic DNA topoisomerase I and DNA-containing oxidative base damages. 7, 8-dihydro-8-oxoguanine and 5-hydroxycytosine. J. Biol. Chem., 274, 8516-8523.
31. Pourquier,P., Ueng,L.M., Kohlhagen,G., Mazumder,A., Gupta,M., Kohn,K.W. and Pommier,Y. (1997) Effects of uracil incorporation, DNA mismatches, and abasic sites on cleavage and religation activities of mammalian topoisomerase I. J. Biol. Chem., 272, 7792-7796.
32. Pommier,Y., Kohlhagen,G., Pourquier,P., Sayer,J.M., Kroth,H. and Jerina,D.M. (2000) Benzo [a]pyrene diol epoxide adducts in DNA are potent suppressors of a normal topoisomerase I cleavage site and powerful inducers of other topoisomerase I cleavages. Proc. Natl Acad Sci. USA, 97, 2040-2045.
33. Pommier,Y., Kohlhagen,G., Laco,G.S., Kroth,H., Sayer,J.M. and Jerina,D.M. (2002) Different effects on human topoisomerase I by minor groove and intercalated deoxyguanonsine adducts derived from two polycyclic aromatic hydrocarbon diol epoxides at or near a normal cleavage site. J. Biol. Chem., 277, 13666-13672.
34. Pommier,Y., Jenkins,J., Kohlhagen,G. and Leteurtre,F. (1995) DNA recombinase activity of eukaryotic DNA topoisomerase I; effects of camptothecin and other inhibitors. Mutat. Res., 337, 135-145.
35. 2 -ethyl-2′-deoxyguanosine. Nucleic Acids Res., 32, 5685-5692.
36. Sanchez,A.M., Minko,I.G., Kurtz,A.J., Kanuri,M., Moriya,M. and Lloyd,R.S. (2003) Comparative evaluation of the bioreactivity and mutagenic spectra of acrolein-derived α-HOPdG and γ-HOPdG regioisomeric deoxyguanosine adducts. Chem. Res. Toxicol., 16 1019-1028.
37. Golan,G., Zharkov,D.O., Grollman,A.P., Dodson,M.L., McCullough,A.K., Lloyd,R.S. and Shoham,G. (2006) Structure of T4 pyrimidine dimer glycosylase in a reduced imine covalent complex with abasic site-containing DNA. J. Mol. Biol, 362, 241-258.
38. Minko,I.G., Zou,Y. and Lloyd,R.S. (2002) Incision of DNA-protein crosslinks by UvrABC nuclease suggests a potential repair pathway involving nucleotide excision repair. Proc. Natl Acad. Sci. USA, 99, 1905-1909.
39. Christmann-Franck,S., Fermandjian,S., Mirambeau,G. and Der Garabedian,P.A. (2007) Molecular modelling studies on the interactions of human DNA topoisomerase IB with pyridoxal-compounds. Biochimie, 89, 468-473.
40. Vermeersch,J.J., Christmann-Franck,S., Karabashyan,L.V., Fermandjian,S., Mirambeau,G. and Der Garabedian,P.A. (2004) Pyridoxal 5′-phosphate inactivates DNA topoisomerase IB by modifying the lysine general acid. Nucleic Acids Res., 32, 5649-5657.
41. Champoux,J.J. (2001) DNA topoisomerases: Structure, function, and mechanism. Annu. Rev. Biochem., 70, 369-413.
42. 2-propano-2′-deoxyguanosine. J. Biol. Chem., 276, 9077-9082.
43. Mao,H., Schnetz-Boutaud,N.C., Weisenseel,J.P., Marnett,L.J. and Stone,M.P. (1999) Duplex DNA catalyzes the chemical rearrangement of a malondialdehyde deoxyguanosine adduct. Proc. Natl Acad. Sci. USA, 96, 6615-6620.
44. Jaxel,C., Capranico,G., Kerrigan,D., Kohn,K.W. and Pommier,Y. (1991) Effect of local DNA sequence on topoisomerase I cleavage in the presence or absence of camptothecin. J. Biol. Chem., 266, 20418-20423.
45. Takebayashi,Y., Pourquier,P., Yoshida,A., Kohlhagen,G. and Pommier,Y. (1999) Poisoning of human DNA topoisomerase I by ecteinascidin 743, an anticancer drug that selectively alkylates DNA in the minor groove. Proc. Natl Acad. Sci. USA, 96, 7196-7201.
46. Jha,A.M., Singh,A.C., Sinha,U. and Kumar,M. (2007) Genotoxicity of crotonaldehyde in the bone marrow and germ cells of laboratory mice. Mutat. Res., 632, 69-77.